跳至主要内容
临床试验/NCT06759116
NCT06759116招募中不适用

Analgesic Effect of Fentanyl Vs Dexmedetomidine As Adjuvant to Bupivacaine in Combined IPACK and Adductor Canal Block After Knee Surgeries

Zagazig University1 个研究点 分布在 1 个国家目标入组 111 人开始时间: 2025年1月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
111
试验地点
1
主要终点
● The total amount of rescue analgesic consumption (tramadol)

研究概览

简要总结

This study will be undertaken to compare the analgesic effects of of fentanyl versus dexmedetomidine as adjuvant to bupivacaine in combined IPACK and ACB for pain management after total knee arthroplasty.

详细描述

  • To measure the total amount of rescue analgesic consumption in the first 48 hours post-operatively in each group
  • To assess pain score in each group by using Numerical Rating Scale (NRS) at rest (static) and during flexion or extension of knee (dynamic) at different time points: PACU, 2 hrs, 4 hrs, 8 hrs, 12 hrs, 24 hrs and 48 hrs.
  • To measure the time of first request of rescue analgesia in each group
  • To record the incidence of adverse events (hematoma, local anesthetic toxicity, infection, nausea and vomiting) and length of hospital stay.
  • Over all patients' satisfaction: The patients will be asked to rate the overall degree of satisfaction of the analgesia by using a 5-points Likert-like verbal scale (1 = very dissatisfied analgesia, 2 = dissatisfied analgesia, and 3 = neutral, 4=satisfied analgesia, and 5=very satisfied analgesia).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

anesthetist not sharing in the study will assess patients

入排标准

年龄范围
21 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •1 - Patient acceptance
  • •Cooperative patients
  • •Age: ≥21 and 85< years' old
  • •Sex: both sexes (males or females).
  • •Physical status: ASA Ι & II& Ш.
  • •Body Mass Index (BMI): ≤ 35 kg/m
  • •Type of operation: elective unilateral knee surgeries (TKA, ACL, knee arthroscopy)

排除标准

  • •. Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site)
  • •Patients with known history of allergy to the study drugs (bupivacaine, dexmedetomidine and fentanyl).
  • •Advanced hepatic, renal, cardiovascular, neurologic and respiratory diseases.
  • •4.Chronic opioid use (more than 3 months or daily oral morphine > 5 mg /day for 1 month)

研究组 & 干预措施

Control group (group C)

Active Comparator

The patient receive unilateral ultrasound guided combined IPACK and ACB with bupivacaine only. two syringes , one for each block , each one contains (20 mL of 0.25% bupivacaine and 1 ml saline)

干预措施: Control group (Procedure)

Dexmedetomidine group (group D)

Active Comparator

The patient receive unilateral ultrasound guided combined IPACK and ACB with bupivacaine only. two syringes , one for each block , each one contains (20 mL of 0.25% bupivacaine and 1 ug/kg dexmedetomidine not exceeding 100 ug (to be completed to 1mL with normal saline if needed). )

干预措施: Dexmedetomidine group (Procedure)

Fentanyl group (group F)

Active Comparator

The patient receive unilateral ultrasound guided combined IPACK and ACB with bupivacaine only. two syringes , one for each block , each one contains (20 mL of 0.25% bupivacaine and 50 mcg fentanyl)

干预措施: Fentanyl group (Procedure)

结局指标

主要结局

● The total amount of rescue analgesic consumption (tramadol)

时间窗: For 48 hrs

● The total amount of rescue analgesic consumption (tramadol) postoperatively in each group

Pain intensity by using Numerical Rating Scale (NRS) at rest (static) and during flexion or extension of knee (dynamic) at different time points

时间窗: 0 hours (basal) ( on arrival to PACU), 2 hrs, 4 hrs, 8 hrs, 12 hrs, 24 hrs and 48 hrs

NRS is 10 cm line numbered from 0 to 10, patients instructed to circle the number that represents his/her pain intensity (0=no pain and 10=maximum pain)

次要结局

  • The time to first request of rescue analgesia (tramadol)(24 hours postoperative)
  • The length of hospital stays(For 48-72 hrs)
  • The incidence of adverse events(For 48 hrs)
  • patient's satisfaction(For 48 hrs)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dina Abdelhameed Elsadek Salem

principle investigator

Zagazig University

研究点 (1)

Loading locations...

相似试验